US FDA approves nasal spray alternative to EpiPen for allergic reactions | Reuters

Oct 25, 2024

Sign up here.

Reporting by Sriparna Roy and Christy Santhosh in Bengaluru; Editing by Devika Syamnath and Shailesh Kuber

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Thomson Reuters

Sriparna reports on pharmaceutical companies and healthcare in the United States. She has a master's degree in English literature and post graduate diploma in broadcast journalism.